Denali Fellow & Adjunct Associate Professor
Denali Therapeutics & University of Minnesota
San Francisco, California
Dr. Robert Thorne joined Denali Therapeutics (South San Francisco, California, USA) as a Denali Fellow in 2018, after over 10 years previously on the faculty at the New York University School of Medicine and the University of Wisconsin-Madison. He has been an Adjunct Associate Professor at the University of Minnesota since 2019 and Head of the Denali Postdoc Program since 2020. Dr. Thorne became the President of the International Brain Barriers Society (IBBS) in 2023, after previously being elected IBBS Vice President in 2017 and co-founding the Society in 2006. He has held many additional leadership roles in his field, highlighted by his serving as Chair of the 2016 ‘Barriers of the CNS’ Gordon Research Conference, co-Chair of the 2019 AAPS-IBBS Workshop on CNS drug delivery, and Principal Organizer for the inaugural Keystone Symposium on ‘Drug Delivery to the Brain’ (2023). Dr. Thorne’s overarching research goal for over three decades has involved identifying how best to deliver proteins, oligonucleotides, and gene therapy vectors to the brain. His varied research interests span diffusion in brain extracellular space, perivascular transport, CSF-ISF exchange, CNS biomarker interpretation, quantitative systems pharmacology, the physiology of the CNS barriers, neuronopathic lysosomal storage disorders, neurodegeneration, and brain cancer.
Monday, October 23, 2023
1:30 PM – 2:30 PM ET